Literature DB >> 16291066

The global burden of diabetic foot disease.

Andrew J M Boulton1, Loretta Vileikyte, Gunnel Ragnarson-Tennvall, Jan Apelqvist.   

Abstract

Diabetic foot problems are common throughout the world, resulting in major economic consequences for the patients, their families, and society. Foot ulcers are more likely to be of neuropathic origin, and therefore eminently preventable, in developing countries, which will experience the greatest rise in the prevalence of type 2 diabetes in the next 20 years. People at greatest risk of ulceration can easily be identified by careful clinical examination of the feet: education and frequent follow-up is indicated for these patients. When assessing the economic effects of diabetic foot disease, it is important to remember that rates of recurrence of foot ulcers are very high, being greater than 50% after 3 years. Costing should therefore include not only the immediate ulcer episode, but also social services, home care, and subsequent ulcer episodes. A broader view of total resource use should include some estimate of quality of life and the final outcome. An integrated care approach with regular screening and education of patients at risk requires low expenditure and has the potential to reduce the cost of health care.

Entities:  

Mesh:

Year:  2005        PMID: 16291066     DOI: 10.1016/S0140-6736(05)67698-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  512 in total

Review 1.  Use of sugar on the healing of diabetic ulcers: a review.

Authors:  Atanu Biswas; Manish Bharara; Craig Hurst; Rainer Gruessner; David Armstrong; Horacio Rilo
Journal:  J Diabetes Sci Technol       Date:  2010-09-01

2.  The major predictors of amputation and length of stay in diabetic patients with acute foot ulceration.

Authors:  Suzan Tabur; Mehmet Ali Eren; Yakup Çelik; Omer Faruk Dağ; Tevfik Sabuncu; Zeynel Abidin Sayiner; Esen Savas
Journal:  Wien Klin Wochenschr       Date:  2014-11-15       Impact factor: 1.704

Review 3.  Diabetic foot disease in people with advanced nephropathy and those on renal dialysis.

Authors:  Agbor Ndip; Lawrence A Lavery; Andrew J M Boulton
Journal:  Curr Diab Rep       Date:  2010-08       Impact factor: 4.810

Review 4.  Role of advanced glycation endproducts and glyoxalase I in diabetic peripheral sensory neuropathy.

Authors:  Megan Jack; Douglas Wright
Journal:  Transl Res       Date:  2012-01-10       Impact factor: 7.012

5.  Methodology for use of a neuroprosthetic to reduce plantar pressure: applications in patients with diabetic foot disease.

Authors:  Manish Bharara; Bijan Najafi; David G Armstrong
Journal:  J Diabetes Sci Technol       Date:  2012-01-01

6.  Multimodal therapy as an algorithm to limb salvage in diabetic patients with large heel ulcers.

Authors:  Ewan B Goudie; Cynthia Gendics; John C Lantis
Journal:  Int Wound J       Date:  2011-09-23       Impact factor: 3.315

7.  An Optical-Fiber-Based Smart Textile (Smart Socks) to Manage Biomechanical Risk Factors Associated With Diabetic Foot Amputation.

Authors:  Bijan Najafi; Hooman Mohseni; Gurtej S Grewal; Talal K Talal; Robert A Menzies; David G Armstrong
Journal:  J Diabetes Sci Technol       Date:  2017-05-17

Review 8.  Activity of mesenchymal stem cells in therapies for chronic skin wound healing.

Authors:  Austin Nuschke
Journal:  Organogenesis       Date:  2013-12-10       Impact factor: 2.500

9.  Sensory neurons and schwann cells respond to oxidative stress by increasing antioxidant defense mechanisms.

Authors:  Andrea M Vincent; Koichi Kato; Lisa L McLean; Mary E Soules; Eva L Feldman
Journal:  Antioxid Redox Signal       Date:  2009-03       Impact factor: 8.401

10.  Linagliptin-associated blistering and ulceration.

Authors:  Cristina Psomadakis; Naima Shahzad; Jonathan Katz
Journal:  BMJ Case Rep       Date:  2017-05-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.